Manidipino Vir (Manidipine Dihydrochloride)

Manidipine Dihydrochloride is used to manage high blood pressure, a condition within the cardiovascular disease spectrum.

• Primary hypertension: lowers systolic and diastolic pressure through arterial vasodilation.
• Secondary hypertension: assists in blood‑pressure control when caused by other disorders.
• Isolated systolic hypertension: reduces elevated systolic readings in older adults.

• Manidipine Dihydrochloride selectively inhibits L‑type calcium channels in vascular smooth‑muscle cells, decreasing calcium influx. This leads to relaxation of arterial smooth muscle, vasodilation, and a consequent reduction in peripheral vascular resistance, which lowers systemic blood pressure.

Manidipine Dihydrochloride may cause a range of adverse reactions.

Common Side Effects

• Headache: mild to moderate intensity.
• Flushing: transient warmth and redness of the skin.
• Peripheral edema: swelling of the ankles or lower legs.
• Dizziness: especially upon standing.
• Tachycardia: increased heart rate.
• Nausea: occasional upset stomach.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure causing faintness.
• Hepatic dysfunction: abnormal liver enzyme elevations.
• Allergic reactions: rash, pruritus, or angioedema.
• Myocardial infarction: rare occurrence in susceptible patients.
• Atrioventricular block: conduction disturbances.
• Renal impairment: worsening kidney function in predisposed individuals.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential risks.

• Blood pressure monitoring: assess baseline and periodic readings.
• Cardiovascular history: review for heart failure or recent myocardial infarction.
• Liver function: check enzymes in patients with hepatic disease.
• Renal function: evaluate creatinine clearance in those with kidney impairment.
• Concomitant antihypertensives: adjust doses to avoid excessive hypotension.
• Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and direct sunlight.

Manidipine Dihydrochloride can interact with several drug classes, influencing efficacy or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase plasma concentrations.
• Simultaneous use with other potent vasodilators (e.g., nitroglycerin): risk of severe hypotension.
• Grapefruit juice: can elevate drug levels leading to toxicity.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance antihypertensive effect, requiring dose adjustment.

• Beta‑blockers: additive blood‑pressure lowering effect.
• Antidiabetic agents: possible enhancement of hypoglycaemia.
• NSAIDs: may blunt antihypertensive response.